Kajian klinikal Epilepsi di Illinois
7 kajian untuk Epilepsi sedang mencari peserta di lokasi di Illinois.
Bandar di Illinois
Teks kajian rasmi (Bahasa Inggeris)
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Lurie Children's Hospital of Chicago, Chicago
Mengambil pesertaFasa 2
1 Day – 6 Months · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05104983Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07594119A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Southern Illinois University School of Medicine, Springfield
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Mengambil pesertaKajian pemerhatian
Sehingga umur 26 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
Mengambil pesertaFasa 3
1 Day – 18 Years · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Jun 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT05716100Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.